Aluminum phthalocyanine chloride - CAS 14154-42-8
Not Intended for Therapeutic Use. For research use only.
Product Name:
Aluminum phthalocyanine chloride
Catalog Number:
Phthalocyanine Chloroaluminum; Chloroaluminum Phthalocyanine; Aluminum phthalocyanine chloride. Chloro(29H,31H-phthalocyaninato)aluminum;(SP-5-12)-chloro(29H,31H-phthalocyaninato(2-)-kappaN29,kappaN30,kappaN31,kappaN32)-Aluminum
CAS Number:
Aluminum phthalocyanine chloride is an blue-green-coloured aromatic macrocyclic compound. It is widely used in dyeing. Phthalocyanine Chloroaluminum is a photosensitizer and it is useful in Photodynamic therapy (PDT).
Molecular Weight:
Molecular Formula:
Quality Standard:
In-house standard
Canonical SMILES:
Chemical Structure
CAS 14154-42-8 Aluminum phthalocyanine chloride

Related Products

(CAS: 204010-55-9)

AG-1801is a bio-active chemical for treatment of cell proliferative diseases.

CAS 34080-08-5 (20S)-Protopanaxatriol

(CAS: 34080-08-5)

20S-Protopanaxatriol (g-PPT), a dammarane-type tetracyclic terpene sapogenin, may be used to study its binding to and modulation of cell function via glucocorto...

CAS 73-31-4 Melatonin

(CAS: 73-31-4)

Melatonin is a hormone produced in the brain by the pineal gland from the amino acid tryptophan.

CAS 104-46-1 cis-Anethol

(CAS: 104-46-1)

Anethole, a widespread plant extract, could be used in various areas like foods and drugs as a flavoring agent. It might also block neuronal excitability.

(CAS: 694443-03-3)

BoNT-IN-1 is a potent inhibitor of Botulinum neurotoxin A light chain (IC50 = 0.9 uM).

CAS 9041-93-4 Bleomycin sulfate

Bleomycin sulfate
(CAS: 9041-93-4)

Bleomycin sulfate is a mixture of the sulfate salts of basic glycopeptide antineoplastic antibiotics isolated from Streptomyces verticillus. Bleomycin sulfate ...

CAS 3458-22-8 IPD Hydrochloride

IPD Hydrochloride
(CAS: 3458-22-8)

IPD is an alkylsulfonate DNA crosslinker.

(CAS: 1418741-86-2)

CHEMBL2426474, also called as UNC1079, the piperidine analog of UNC1021 that has binding affinity to L3MBTL3 in human G401 cells by Western blot based pulldown ...

(CAS: 1620692-60-5)

KPU-300, a diketopiperazine derivative, has been found to be an antimicrotubule agent and exhibit cytotoxicity against HT-29 cells. IC50: 7.0 nM.

CAS 61276-17-3 Verbascoside

(CAS: 61276-17-3)

Verbascoside is a bioactive polyphenol from olive oil mill wastewater with known antioxidant activity, which is a protein kinase C inhibitor.

CAS 58-15-1 Amidopyrine

(CAS: 58-15-1)

Aminophenazone (or aminopyrine) is a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis.

CAS 541-15-1 L-carnitine

(CAS: 541-15-1)

L-carnitine is constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyper...

CAS 3685-84-5 Meclofenoxate hydrochloride

Meclofenoxate hydrochloride
(CAS: 3685-84-5)

Meclofenoxate (Lucidril), also known as centrophenoxine, is a drug used to treat the symptoms of senile dementia and Alzheimer's disease. It is an ester of dime...

(CAS: 75041-32-6)

NSC134754 is a Heat Shock Factor 1 (HSF1) inhibitor. It can induce inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating lig...

CAS 891025-25-5 BAMB-4

(CAS: 891025-25-5)

BAMB-4 is a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A((ITPKA). It exhibits the lowest inhibition frequency among the InsP...

(CAS: 112227-15-3)

CP-71362 is a pentapeptide renin inhibitor. It is selective for the canine enzyme.

CAS 75706-12-6 Leflunomide

(CAS: 75706-12-6)

Leflunomideinhibits the reproduction of rapidly dividing cells by inhbiting the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH).

CAS 2934-97-6 Tetrahydropalmatine

(CAS: 2934-97-6)

Tetrahydropalmatine depletes neurotransmitters such as dopamine, noradrenaline and serotonin. L-Tetrahydropalmatine is an inhibitor of D3DR. L-Tetrahydropalmati...

CAS 3416-24-8 D-Glucosamine (Free Base)

D-Glucosamine (Free Base)
(CAS: 3416-24-8)

An amino sugar, part of the structure of the polysaccharides chitosan and chitin, is made naturally in the form of glucosamine-6-phosphate, and is the biochemic...

CAS 1217022-63-3 PTC-209 hydrobromide

PTC-209 hydrobromide
(CAS: 1217022-63-3)

Polycomb complex protein BMI-1 is a polycomb ring finger oncogene that regulates the p16 and p19 cell cycle inhibitor genes. It is necessary for efficient self-...

Reference Reading

1.Highly Efficient Photodynamic Therapy Colloidal System Based On Chloroaluminum Phthalocyanine/Pluronic Micelles.
Py-Daniel KR1, Namban JS2, de Andrade LR1, de Souza PE2, Paterno LG3, Azevedo RB1, Soler MA4. Eur J Pharm Biopharm. 2016 Mar 24. pii: S0939-6411(16)30104-7. doi: 10.1016/j.ejpb.2016.03.028. [Epub ahead of print]
Phthalocyanine derivatives comprise the second generation of photosensitizer molecules employed in photodynamic therapy (PDT) and have attracted much attention due to their outstanding photosensitizing performance. Most phthalocyanines are hydrophobic compounds that require association to drug delivery systems for clinical use. In this study, formulations of Pluronic F127 micelles incorporated with chloroaluminum phthalocyanine, or else F127/AlClPc, were produced at optimized conditions aiming at efficient and biocompatible PDT colloidal systems. Absorption/emission spectroscopies, as well as dynamic light scattering were performed to evaluate the optimum conditions for the F127 micelle formation and AlClPc incorporation. The micelles formation was attained with F127 concentrations ranging from 50 to 150 mg mL-1. At these conditions, AlClPc photosensitizer molecules were encapsulated into the hydrophobic micelle core and, therefore, readily solubilized in physiological medium (PBS pH 7.
2.Reactive oxygen and nitrogen species disturb Ca(2+) oscillations in insulin-secreting MIN6 β-cells.
Antonucci S1,2, Tagliavini A3, Pedersen MG3. Islets. 2015 Jul 4;7(4):e1107255. doi: 10.1080/19382014.2015.1107255.
Disturbances in pulsatile insulin secretion and Ca(2+) oscillations in pancreatic β-cells are early markers of diabetes, but the underlying mechanisms are still incompletely understood. Reactive oxygen/nitrogen species (ROS/RNS) are implicated in reduced β-cell function, and ROS/RNS target several Ca(2+) pumps and channels. Thus, we hypothesized that ROS/RNS could disturb Ca(2+) oscillations and downstream insulin pulsatility. We show that ROS/RNS production by photoactivation of aluminum phthalocyanine chloride (AlClPc) abolish or accelerate Ca(2+) oscillations in the MIN6 β-cell line, depending on the amount of ROS/RNS. Application of the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase (SERCA) inhibitor thapsigargin modifies the Ca(2+) response to high concentrations of ROS/RNS. Further, thapsigargin produces effects that resemble those elicited by moderate ROS/RNS production. These results indicate that ROS/RNS interfere with endoplasmic reticulum Ca(2+) handling.
3.Photodynamic therapy leads to complete remission of tongue tumors and inhibits metastases to regional lymph nodes.
Bicalho LS1, Longo JP, Cavalcanti CE, Simioni AR, Bocca AL, Santos Mde F, Tedesco AC, Azevedo RB. J Biomed Nanotechnol. 2013 May;9(5):811-8.
In patients diagnosed with oral cancer, the most important prognostic indicator for patient survival after primary treatment is metastasis to the cervical lymph nodes or distal sites. Therefore, we evaluated the utility of photodynamic therapy (PDT) mediated by aluminum-chloride-phthalocyanine entrapped in liposomes for the prevention of metastasis to regional cervical lymph nodes in the Erhlich tongue cancer model. The PDT protocol led to complete remission of tongue tumours and prevented the occurrence of regional metastasis. The prevention of regional metastasis was confirmed by histopathological and immunohistochemical analyses. In addition, PDT treatment increased the overall survival and reduced weight loss relative to control tumour-bearing mice. Thus, PDT should be clinically evaluated for use in the prevention of cervical lymph node metastasis in patients with oral cancer.
4.The photosensitized oxidation of mixture of parabens in aqueous solution.
Gryglik D1, Gmurek M. Environ Sci Pollut Res Int. 2015 Jan 16. [Epub ahead of print]
The work presents results of studies on the photosensitized oxidation of mixture of five parabens (methyl-, ethyl-, propyl-, n-butyl-, and benzylparaben) in aqueous solution. Aluminum phthalocyanine chloride tetrasulfonic acid and xenon lamp simulating solar radiation were used as a photosensitizer and a light source, respectively. The purpose was to investigate the influence of inhibitory effect compounds present in the mixture on the reaction rate. The influence of the addition of second photosensitizer on the parabens degradation rate was investigated. The effect of additives: tert-butanol - hydroxyl radical scavenger and sodium azide - singlet oxygen scavenger on reaction course was also determined. The transformation products formed during the photosensitized oxidation process were analyzed by UPLC-MS/MS. The efficiency of photosensitized oxidation of parabens with natural sunlight irradiation in the central Poland was checked.